KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway

Figure 5

NU9056 inhibits ATC xenograft growth in mice. The SPF mice were injected ATC cells at the right flanks and were divided into the control or NU9056 group. The tumor growth curves were calculated (A). After 21 days, mice were killed and tumors were removed (B, C). Then, the tumor weights of each group were measured (D). N = 10 mice per group. .

(a)

(b)

(c)

(d)